Clinical Trials Logo

Clinical Trial Summary

The greenlight laser has an absorption maximum which is exactly the same as for hemoglobin. In the presence of hemoglobin, its application causes vaporization of the tissue and this effect depends on the concentration of hemoglobin in the respective tissue. Therefore, increase of blood-flow in the tissue (here: prostate gland) should exert better efficacy of the laser application and consequently shortening of the required duration of laser application.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00461123
Study type Interventional
Source Bayer
Contact
Status Completed
Phase Phase 2
Start date March 2007
Completion date June 2008

See also
  Status Clinical Trial Phase
Completed NCT01732991 - Assessing the Impact of the PVP With Greenlight Laser Using Prostatic MRI and Contrast-enhanced Ultrasound N/A
Completed NCT02074644 - Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia N/A
Active, not recruiting NCT02689830 - Prostate Embolization for Acute Urinary Retention Study N/A
Completed NCT02015806 - Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices N/A
Completed NCT02943070 - Rezum I Pilot Study for Benign Prostatic Hyperplasia N/A
Completed NCT02940392 - Rezum FIM Optimization Study N/A
Completed NCT04331301 - Bipolar Needlescopic Enucleation Versus Vapoenucleation of BPH N/A
Completed NCT00021814 - Medical Therapy of Prostatic Symptoms Phase 3